nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Budget impact analysis in economic evaluation: a proposal for a clearer definition
|
Garattini, Livio |
|
2011 |
12 |
6 |
p. 499-502 |
artikel |
2 |
Comparison of cost-weights scales methodologies in the perspective of a financing system based on pathologies
|
Pirson, M. |
|
2010 |
12 |
6 |
p. 503-508 |
artikel |
3 |
Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom
|
Botteman, M. F. |
|
2010 |
12 |
6 |
p. 575-588 |
artikel |
4 |
Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis
|
Medin, Emma |
|
2010 |
12 |
6 |
p. 509-519 |
artikel |
5 |
Direct costs of Alzheimer’s disease in Germany
|
Kiencke, Peter |
|
2010 |
12 |
6 |
p. 533-539 |
artikel |
6 |
Do you believe in magic? Improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience
|
Gorecki, Paul K. |
|
2010 |
12 |
6 |
p. 521-531 |
artikel |
7 |
Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments?
|
Hvenegaard, Anne |
|
2010 |
12 |
6 |
p. 541-551 |
artikel |
8 |
How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives
|
Gür Ali, Özden |
|
2010 |
12 |
6 |
p. 553-562 |
artikel |
9 |
Market structure and hospital–insurer bargaining in the Netherlands
|
Halbersma, R. S. |
|
2010 |
12 |
6 |
p. 589-603 |
artikel |
10 |
The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain
|
Moreno-Torres, Iván |
|
2010 |
12 |
6 |
p. 563-573 |
artikel |